Improved mycobacterial tetracycline inducible vectors

Plasmid

Volumn 64, Issue 2, 2010, Pages 69-73

  Williams, Kerstin J ^a   Joyce, Graham ^a   Robertson, Brian D ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Conditional gene expression; Mycobacteria; Tetracycline inducible

Indexed keywords

AMINO ACID; PROTEIN TETR; PROTEIN TETRO; REPRESSOR PROTEIN; TETRACYCLINE; UNCLASSIFIED DRUG; BACTERIAL PROTEIN; DOXYCYCLINE; LUCIFERASE;

ARTICLE; CONTROLLED STUDY; GENE CONSTRUCT; GENE MUTATION; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; MOLECULAR CLONING; NONHUMAN; PLASMID; PROMOTER REGION; DOSE RESPONSE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENE VECTOR; GENETIC ENGINEERING; GENETICS; METABOLISM; MYCOBACTERIUM SMEGMATIS; OPERATOR GENE; PROCEDURES; REPORTER GENE;

BACTERIAL PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXYCYCLINE; GENE EXPRESSION REGULATION, BACTERIAL; GENES, REPORTER; GENETIC ENGINEERING; GENETIC VECTORS; LUCIFERASES; MYCOBACTERIUM SMEGMATIS; OPERATOR REGIONS, GENETIC; PROMOTER REGIONS, GENETIC; REPRESSOR PROTEINS; TETRACYCLINE;

CORYNEBACTERINEAE;

EID: 77954141741     PISSN: 0147619X     EISSN: 10959890     Source Type: Journal    
DOI: 10.1016/j.plasmid.2010.04.003     Document Type: Article

References (14)

1. Baumeister R., Helbl V., Hillen W. Contacts between Tet repressor and tet operator revealed by new recognition specificities of single amino acid replacement mutants. J. Mol. Biol. 1992, 226(4):1257-1270.
2. Blokpoel, M.C. et al., 2005. Tetracycline-inducible gene regulation in mycobacteria. Nucleic Acids Res. 33(2), e22.
3. Carroll P., Muttucumaru D.G., Parish T. Use of a tetracycline-inducible system for conditional expression in Mycobacterium tuberculosis and Mycobacterium smegmatis. Appl. Environ. Microbiol. 2005, 71(6):3077-3084.
4. Ehrt S., Schnappinger D. Controlling gene expression in mycobacteria. Future Microbiol. 2006, 1(2):177-184.
5. Ehrt, S. et al., 2005. Controlling gene expression in mycobacteria with anhydrotetracycline and Tet repressor. Nucleic Acids Res. 33(2), e21.
6. Guo X.V., et al. Silencing Mycobacterium smegmatis by using tetracycline repressors. J. Bacteriol. 2007, 189(13):4614-4623.
7. Hernandez-Abanto S., et al. Tetracycline-inducible gene expression in mycobacteria within an animal host using modified Streptomyces tcp830 regulatory elements. Arch. Microbiol. 2006, 186(6):459-464.
8. Hillen W., Berens C. Mechanisms underlying expression of Tn10 encoded tetracycline resistance. Annu. Rev. Microbiol. 1994, 48:345-369.
9. Kamionka A., et al. Two mutations in the tetracycline repressor change the inducer anhydrotetracycline to a corepressor. Nucleic Acids Res. 2004, 32(2):842-847.
10. Sassetti C.M., Rubin E.J. Genetic requirements for mycobacterial survival during infection. Proc. Natl. Acad. Sci. 2003, 100(22):12989-12994.
11. Sassetti C.M., Boyd D.H., Rubin E.J. Genes required for mycobacterial growth defined by high density mutagenesis. Mol. Microbiol. 2003, 48(1):77-84.
12. Tauch A., et al. TetZ, a new tetracycline resistance determinant discovered in gram-positive bacteria, shows high homology to gram-negative regulated efflux systems. Plasmid 2000, 44(3):285-291.
13. Velayati A.A., et al. Totally drug-resistant tuberculosis strains: evidence of adaptation at the cellular level. Eur. Respir. J. 2009, 34(5):1202-1203.
14. Williams K.J., Duncan K. Current strategies for identifying and validating targets for new treatment-shortening drugs for TB. Curr. Mol. Med. 2007, 7(3):297-307.